Clinical Trials
LACOG 0211 - ALK
Title
A clinical and epidemiologic study of EML4-ALK and other ALK fusions genes in lung cancer patients in Latin American.
Primary Objective
To estimate the prevalence of EML4-ALK fusio gene in Latin American in patients with non squamous-cell lung carcinoma.
Design
This is a retrospective study to explore the prevalence of a specific biomarker in a sequential unselected cohort of non squamous NSCLC patients from Latin American cancer treatment institutions.
Sample size: 1154
LACOG Study Coordinators: Carlos Gil, Clarissa Baldotto, Carlos Barrios
Status: Recruiting
Sponsor: INCA
Contact
lacog@lacog.org.br
Phone: 55 51 3384 5334